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AbstrAct
background A substantial reduction in neonatal mortality 
is the main priority to reduce under-five mortality. A clear 
understanding of the variation in neonatal mortality and the 
underlying causes is important for targeted intervention. 
We aimed to explore variation in neonatal mortality and 
identify underlying causes of variation in neonatal mortality 
in sub-Saharan Africa (SSA).
Methods This ecological study used 2012 publicly available 
data from WHO, the US Agency for International Development 
and the World Bank. Variation in neonatal mortality across 
49 SSA countries was examined using control chart and 
explanatory spatial data analysis. Associations between 
country-level characteristics and neonatal mortality were 
examined using linear regression analysis.
results The control chart showed that 28 (57%) SSA 
countries exhibited special-cause variation, 14 countries 
were below and 14 above the 99.8% control-limits. The 
remaining 21 (43%) SSA countries showed common-
cause variation. No spatial clustering was observed for 
neonatal mortality (Global Moran’s I statistic −0.10; 
p=0.74). Linear regression analysis showed HIV/AIDS 
prevalence among the population of reproductive age to 
be positively associated with neonatal mortality (β=0.463; 
95% CI 0.135 to 0.790; p<0.01). Declining socioeconomic 
deprivation (β=−0.234; 95% CI −0.424 to −0.044; 
p<0.05) and high quality of healthcare governance 
(β=−1.327, 95% CI −2.073 to −0.580; p<0.01) were 
inversely associated with neonatal mortality.
conclusion This study shows a wide variation in neonatal 
mortality in SSA. A substantial part of this variation can 
be explained by differences in the quality of healthcare 
governance, prevalence of HIV and socioeconomic 
deprivation. Future studies should validate our findings 
using more rigorous epidemiological study designs.
bAckground
A substantial reduction in neonatal mortality 
is one of the main priorities to realise sustain-
able development goal 3 (SDG 3—aims to 
ensure healthy lives and promote well-being 
for all at all ages) given that neonatal death 
accounts for 40% of under-five mortality.1 
Globally, about 10 000 neonates are dying 
daily,2 an estimate that may be signifi-
cantly higher considering the likelihood of 
under-reporting,3 4 especially in low-income 
and middle-income countries.5 Sub-Saharan 
Africa (SSA) has the highest rate of neonatal 
mortality worldwide,6 with some degree of 
variation across SSA countries and only minor 
declines over the last two decades.3 Exam-
ining variation in health outcomes across 
similar settings is an important aspect of 
epidemiological research to guide assessment 
of inequality in health outcomes,7 8 health 
system performance monitoring9–11 and 
healthcare governance.12
Exploring variation in health outcome 
requires collection of valid data, appropriate 
application of statistical analyses and adequate 
knowledge of exploring variation. Several 
studies emphasised the approach proposed 
by Shewhart and Deming on how to investi-
gate and deal with variation.13–15 According to 
their findings, variation is a product of multiple 
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Key questions
What is already known about this topic?
 ► Previous studies have linked variation in neonatal 
mortality with paternal, maternal, neonatal and 
socioeconomic factors at individual-level.
 ► In addition, experts in neonatal health have 
advocated for increase in health financing, 
healthcare coverage and other interventions as 
means of improving survival in early life.
What are the new findings?
 ► This study determined the impact of healthcare 
governance on neonatal survival, which no previous 
studies have examined.
 ► Increase in healthcare coverage and financing 
without good quality of healthcare governance may 
not improve neonatal survival.
recommendations for policy
 ► As governments in SSA is increasing health 
financing, health human resources and health 
service coverage, it is important to improve the 
quality of healthcare governance to avoid wastage.
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Table 1 Descriptive characteristics of 49 sub-Saharan African countries
Country characteristics Mean (SD; range)
Neonatal mortality (per 1000 live births) 30.1 (9.8; 8 to 50)
HIV prevalence (%) 4.9 (6.5; 0.2 to 26.5)
Health financing (US$ per person) 209.6 (313.4; 17 to 1642.7)
Health human resources (per 1000 people) 0.6 (0.9; 0.2 to 4.7)
Physicians per 1000 people 0.2 (0.28; 0.01 to 1.51)
Nurses and midwives per 1000 people 1.1 (1.46; 0.03 to 7.92)
Health service delivery (%) 43.4 (18.9; 1.8 to 87.6)
Contraceptive prevalence (%) 28.1 (19.3; 4 to 75.9)
Skilled delivery (%) 59.1 (21.9; 10 to 99.2)
Health governance (score ranged from −15 to +15) - 4.1 (3.8; −13.7 to 5.0)
Country socioeconomic status 56.0 (14.9; 29.5 to 95.9)
Literacy rate (% of people aged 15 and above) 65.0 (19.1; 27 to 94.2)
Poverty rate (%) 47.5 (18.3; 2 to 76.8)
Access to improved water source (%) 70.6 (17.0; 29.5 to 99.8)
Access to improved sanitation facilities (%) 35.9 (23.0; 8.9 to 97.1)
Figure 1 Control chart.
factors, and every system is subjected to both common 
(expected) and special-cause (unexpected) variation. This 
concept has been applied in health system research.9 16
In common-cause variation, it is expected that the devia-
tion of the estimated health outcome for a particular setting 
should be within 3 standard deviations (SD) of the overall 
average of the estimated health outcome for all settings.13 
In other words, the estimated health outcome should be 
within so-called ‘control limits’.13 Although such variation 
is referred to as common-cause variation, it does not imply 
that the causes of variation are identical across the settings 
within the control limits, but that a combination of different 
multiple factors might have influenced the observed health 
outcome in these settings. Thus, the combined effect of 
these multiple factors on health outcome for each popu-
lation is similar, because the effect estimates are all within 
the control limits.
In case of special-cause variation, the health outcome 
of that setting is expected to be outside the 3 SD of the 
overall average of the estimated health outcomes for all 
the settings. Factors responsible for such variation usually 
have an unexpected high impact on the observed health 
outcome. To thoroughly examine variation in health 
outcome across different populations, revealing the exis-
tence of common-cause and special-cause variation is a 
key aspect. In addition, it is important to visualise spatial 
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Table 2 Global and local spatial autocorrelation for 
neonatal mortality in sub-Saharan Africa
Country
Local Moran’s 
I statistic (p value)
Angola −0.2034 (0.6473)
Benin Republic −0.0077 (0.4859)
Botswana 0.2638 (0.2713)
Burkina Faso −0.0706 (0.5488)
Burundi −0.1874 (0.6139)
Cameroon −0.1784 (0.6588)
Central Africa Republic 0.3505 (0.1849)
Chad 0.1301 (0.3559)
Côte d'Ivoire −0.0065 (0.4829)
Congo Brazzaville 0.0095 (0.4677)
Congo Democratic Republic −0.1832 (0.7052)
Djibouti 0.0103 (0.4750)
Equatorial Guinea −0.1604 (0.5785)
Eritrea 0.4242 (0.2089)
Ethiopia 0.0662 (0.4142)
Gabon 0.0502 (0.4464)
Gambia 0.4236 (0.3243)
Ghana −0.0975 (0.5525)
Guinea Liberia 0.1890 (0.2854)
Guinea-Bissau −0.5647 (0.7843)
Kenya 0.1532 (0.3354)
Lesotho −3.0964 (0.9991)
Liberia −0.6433 (0.8681)
Malawi 0.5700 (0.1416)
Mali −0.0743 (0.5527)
Mauritania 0.0342 (0.4660)
Mozambique 0.1434 (0.3279)
Namibia 0.0885 (0.3935)
Niger −0.1910 (0.6549)
Nigeria −0.0856 (0.5514)
Rwanda 0.1301 (0.3721)
Senegal −0.5428 (0.8926)
Sierra Leone −0.3441 (0.6792)
Somalia −0.5647 (0.8354)
South Africa 0.0056 (0.4682)
Sudan 0.0057 (0.4651)
Swaziland 0.2429 (0.3486)
Tanzania 0.3956 (0.0925)
Uganda −0.0616 (0.5268)
Togo 0.4280 (0.1396)
Zambia 0.0242 (0.4390)
Zimbabwe −0.7644 (0.9617)
Global Moran’s I statistic=−0.0925; p=0.7393, Geary’s C 
statistic=1.0640; p=0.7116.
distribution of health outcomes across populations and 
settings to detect any unusual pattern in terms of spatial 
clustering and outliers. Findings from such investigations 
may provide evidence to formulate targeted interven-
tions aimed to improve health outcomes.17 18
Beyond the assessment of variation in neonatal mortality 
across SSA, the current study seeks to identify underlying 
factors that could explain the variation in neonatal mortality 
by considering country characteristics such as quality of 
healthcare governance, health financing, human health 
resources, health service delivery and the country’s socio-
economic status. As SSA accommodates almost 70% of all 
people living with HIV globally19 with >500 000 newborns 
infected annually,20 we considered the prevalence of HIV 
among the population of reproductive age as a potential 
factor to explain variation in neonatal mortality.
MetHods 
study design and data collection 
This ecological study uses 2012 publicly available data from 
WHO,21 the US Agency for International Development22 
and the World Bank23 repositories for 49 SSA countries. 
Aggregate data at country level on neonatal mortality, illit-
eracy and poverty rate, percentage of safe water coverage, 
improved sanitation facilities, HIV prevalence among the 
population of reproductive age (ie, 15–49 years), health 
governance, health human resources, health delivery and 
health financing were extracted.
study variables
Outcome (dependent)
Neonatal mortality was defined as the number of deaths 
within the first 28 days of life per 1000 live births.
Country-level characteristics (independent)
Country-level characteristics considered to explain the 
underlying causes of variation in neonatal mortality were:
1. Prevalence of HIV infection among the population of 
reproductive age (ie, 15–49 years); 
2.  Health financing based on per capita total expendi-
ture on health at purchasing power parity (PPP) meas-
ured in US$, that is, the ratio of total expenditure on 
health (private and public) and the total population; 
expressed in US$ per person per year;
3. Health service delivery assessed by the average pro-
portion of the population using contraceptives 
among women aged 15–49 years and births attended 
by skilled health staff;
4. Health human resources assessed by the average num-
ber of physicians and nurses per 1000 people; 
5.  Quality of health governance as assessed by political 
stability, government effectiveness, voice and account-
ability, rule of law, regulatory quality, political stability 
and control of corruption. Each of these six areas di-
rectly impacting health system operations was assessed 
based on points ranging from −2.5 to +2.5; higher 
points indicate better quality of health governance. 
Total health governance performance rating scores 
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Figure 2 Relationships between country-level characteristics and neonatal mortality in sub-Saharan Africa (SSA).
range from −15 to +15; higher scores indicate better 
quality of health governance, respectively. Detailed 
information on assessment of health governance has 
been published elsewhere.24
6.  Country’s socioeconomic index was measured by 
use of the average proportion of the population that 
are literate, live above poverty and have access to safe 
water and improved sanitation facilities. Literacy rate 
was defined as the percentage of people aged 15 years 
and above who can read and write. Poverty rate was 
defined as the percentage of the population living 
below poverty line (<US$1.25/day).22
statistical analysis
Descriptive statistics
The range, mean and SD of neonatal mortality and coun-
try-level characteristics were estimated. A mixed-effect 
model was applied to estimate the weighted average of 
neonatal mortality using their variance as weight. Statis-
tical analysis was performed using R statistical package.25
Control chart 
A control chart was constructed by plotting neonatal 
mortality rates on the y-axis against a measure of their 
precision, that is, SD on the x-axis. The chart has five 
horizontal lines, one central line with two lines below and 
above it. The central line indicates the overall neonatal 
mortality while the two additional lines at 95% limits (≈2 
SD) and 99.8% limits (≈3 SD) on both sides of the central 
line represent 95% limits and 99.8% limits of the overall 
estimate of neonatal mortality. Countries with a neonatal 
mortality rate within the 99.8% control limits (≈3 SD) are 
considered to show common-cause variation while those 
outside the 99.8% control limits are considered to exhibit 
special-cause variation. Statistical analysis was performed 
using Stata statistical package V.11.26
Spatial data analysis
Pfeiffer et al and Anselin et al have described the applica-
tion of Global Spatial Autocorrelation (GSA) and Local 
Indicators of Spatial Autocorrelation (LISA).27 28 In this 
study, we used Explanatory Spatial Data Analysis (ESDA) to 
estimate GSA that indicates overall clustering or non-ran-
domness, that is, assessing the degree of overall similarity in 
the spatial pattern of neonatal mortality across SSA coun-
tries. Since GSA cannot express the degree of similarity 
between each country and its neighbouring countries with 
regard to neonatal mortality, we applied LISA to determine 
the presence of significant spatial patterns of neonatal 
mortality across SSA countries. Non-randomness in the 
spatial pattern of neonatal mortality was identified in terms 
of significant spatial clustering or outliers. The estimated 
Local Moran’s I statistic was used to assess the significance 
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Figure 3 Unadjusted associations between country-level characteristics and neonatal mortality in sub-Saharan Africa (SSA).
of local clusters and outliers. Overall, four identifiable cate-
gories of local spatial association or local spatial autocorre-
lation can be observed: two categories indicate clustering 
while the other two suggest outliers. Hot spot local spatial 
association (clustering of countries with high incidence of 
neonatal mortality) and cold spot local spatial association 
(clustering of countries with low incidence of neonatal 
mortality) indicate clustering. High-low local spatial associ-
ation (a country with high incidence of neonatal mortality 
surrounded by neighbouring countries with low incidence 
of neonatal mortality) and low-high local spatial associa-
tion (a country with low incidence of neonatal mortality 
surrounded by neighbouring countries with high inci-
dence of neonatal mortality) indicate outliers.
Associations between country-level characteristics and neonatal 
mortality 
Associations between neonatal mortality and country-level 
characteristics were visualised by use of bar chart and 
two-way scatter plot with a prediction line and 95% CI. Pair-
wise correlation test was used to determine the strength of 
the relationships between country-level characteristics and 
neonatal mortality. Based on the observed Moran’s I statistic, 
spatial regression analysis was not considered29; instead a 
linear regression analysis was applied to examine the rela-
tionships between neonatal mortality and country-level char-
acteristics. Univariable analysis was performed to examine 
the crude relationships between neonatal mortality and 
each country characteristic. Thereafter, all the prespecified 
country characteristics were included in a multivariable 
linear regression model. Model reduction was performed 
based on the significance of each variable and adjusted R2, 
country characteristics that were now statistically signifi-
cant were removed one after the other and the model that 
explained the observed variation in neonatal mortality best 
was determined based on the adjusted R2 statistics of the 
model. The underlying assumptions for linear regression 
analysis were checked. We used visual scatter plot to check for 
linearity relationship between the predictors and neonatal 
deaths per 1000 live births. Furthermore, we confirmed if 
the residuals were normally distributed and whether or not 
the model exhibited homoscedasticity using residual plot 
and White’s test, respectively. In addition, Breusch-Pagan 
test was applied to confirm if the model exhibited homosce-
dasticity. Presence of multicollinearity was assessed using 
variance inflation factor and tolerance test. Statistical signif-
icance of the association was determined by two-tailed Wald 
test at significance level of alpha equal to 5%.
ethical approval
For analysis of anonymous publicly available data, no 
ethical approval is required.21 23
results
descriptive statistics
The summary statistics of the 49 countries included in the 
analysis are shown in table 1. Across countries neonatal 
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Figure 4 Relationships between country-level characteristics and neonatal mortality for countries below, within and above the 
control limits. SSA, sub-Saharan Africa.
mortality ranged from 8 to 50 per 1000 live births (average 
30.1 per 1000 live births, SD 9.8 per 1000 live births). 
The prevalence of HIV among adults of reproductive age 
ranged from 0.2% to 26.5% (average 4.9%, SD 6.5%). 
The average literacy and poverty rates were 65% and 
47%, respectively. Contraceptive use was reported for 
28% of women; 59% of all deliveries were reported to be 
supervised by a skilled healthcare provider. An average of 
six health professionals cared for a population of 10 000. 
US$209.6  was spent on health per person per year with 
a wide disparity ranging from US$17 to US$1642 per 
person per year. Only eight countries (Botswana, Equa-
torial Guinea, Gabon, Mauritius, Seychelles, Swaziland, 
South Africa and Namibia) spent up to US$250 per 
person per year, the rest committed <US$100 per person 
per year. Quality of healthcare governance was low with 
an average of −4.1. Only the Seychelles, Mauritius, Cape 
Verde, Namibia, Botswana, Ghana and South Africa had 
a positive healthcare governance score.
special-cause and common-cause variations in neonatal 
mortality
Figure 1 shows the results of the control chart that 
explored variation in neonatal mortality across 49 SSA 
countries. The weighted mean of neonatal mortality rates 
was 29.8 per 1000 live births. Neonatal mortality rates in 
21 SSA countries (43%) were within the 99.8% control 
limits. Variation observed within this limits suggests 
common-cause variation. Neonatal mortality rates in 14 
SSA countries were above and in 14 countries below the 
99.8% control limits, indicating special-cause variation in 
28 (57%) SSA countries.
geographical variation/clustering in neonatal mortality
Table 2 shows both global and local spatial autocorrela-
tion for neonatal mortality among SSA countries. The 
global Moran’s I statistic (Moran’s I statistic=−0.0925; 
p=0.74) and Geary’s C statistic (Geary’s C statistic=1.0640; 
p=0.71) were not significant indicating absence of spatial 
clustering of neonatal mortality rates. The local spatial 
autocorrelation estimates for neonatal mortality were 
similarly not significant indicating absence of local 
spatial autocorrelation between any SSA country and 
neighbouring countries.
Associations between country-level characteristic and 
neonatal mortality
The relationships between country-level characteris-
tics (HIV prevalence, health financing, health human 
resources, health service delivery, health governance 
and country socioeconomic status) and neonatal 
mortality are shown in figure 2. No relationship was 
group.bmj.com on November 17, 2017 - Published by http://gh.bmj.com/Downloaded from 
Kayode GA, et al. BMJ Glob Health 2017;2:e000209. doi:10.1136/bmjgh-2016-000209 7
BMJ Global Health
Table 3 Association between prespecified country characteristics and neonatal death
Country characteristics Univariable model Multivariable model
β (95% CI) β (95% CI)
HIV prevalence 0.019 (−0.429 to 0.467) 0.463 (0.135 to 0.790)**
Health financing −0.011 (-0.020 to −0.002)* ###
Health human resources −5.962 (-8.870 to −3.055)*** ###
Health service delivery −0.290 (-0.422 to −0.158)*** ###
Health governance −1.707 (-2.282 to −1.133)*** −1.327 (−2.073 to −0.580)**
Country socioeconomic index −0.408 (-0.562 to −0.254)*** −0.234 (−0.424 to −0.044)*
*p<0.05; **p<0.01; ***p<0.001; β regression coefficient, ### variable omitted in the final model based on adjusted R2.
observed between HIV prevalence among the popula-
tion of reproductive age and neonatal mortality. HIV 
prevalence rates were lowest for Cape Verde, Mauri-
tania, Madagascar, Niger, Senegal and Somalia and 
highest for Swaziland, Lesotho, Botswana, South Africa, 
Zimbabwe and Namibia. In general, neonatal mortality 
was inversely related to healthcare financing, health 
human resource capacity, coverage of health service 
delivery quality of healthcare governance and socioeco-
nomic index of the country.
Further quantitative assessment of relationships 
between country characteristics and neonatal mortality 
using two-way scatter plots with a prediction line and 
95% CI showed no relationship between HIV prev-
alence and neonatal mortality (figure 3). Financial 
investment in health was inversely related to neonatal 
mortality (correlation coefficient r=0.35; p=0.01). 
Similarly, country’s health human resources capacity 
showed an inverse linear relationship with neonatal 
mortality (correlation coefficient r=0.52; p<0.001). An 
inverse relationship was observed between the popula-
tion coverage of health service delivery and neonatal 
mortality (correlation coefficient r=0.54; p<0.001). As 
country’s quality of healthcare governance increased 
neonatal mortality decreased (correlation coefficient 
r=0.52; p<0.001); a similar relationship was observed 
for socioeconomic index (correlation coefficient 
r=0.61; p<0.001). The pooled characteristics (HIV 
prevalence, health financing, health human resources, 
health service delivery, quality of healthcare gover-
nance and country socioeconomic index) of the coun-
tries below, within and above the control limits (≈3 SD) 
were compared with average neonatal mortality using 
multiple double-bar charts as shown in figure 4. The 
results clearly show linear inverse relationships of the 
country’s health financing, health human resources, 
health service delivery coverage, health governance 
performance and socioeconomic index with neonatal 
mortality. HIV prevalence appeared not to have a signif-
icant relationship with neonatal mortality.
The results of the linear regression analysis to 
examine the association between country characteristic 
and neonatal death are shown in table 3. In the multi-
variable regression model, three country characteristics 
were observed to have a significant independent asso-
ciation with neonatal death. The quality of healthcare 
governance was the strongest underlying factor for 
neonatal survival; for every unit increase in country’s 
quality of healthcare governance neonatal mortality 
declined by −1.327 per 1000 live births (95% CI −2.073 
to −0.580; p<0.01). In addition, for every unit decline 
in the percentage of population under socioeconomic 
deprivation, neonatal mortality declined by −0.234 per 
1000 live births (95% CI −0.424 to −0.044; p<0.05), 
whereas for every unit increase in the prevalence of 
HIV/AIDS among the population of reproductive age, 
neonatal mortality increased by 0.463 per 1000 live 
births (95% CI 0.135 to 0.790; p<0.01).
discussion
This study shows a vast geographical variation in neonatal 
mortality across 49 SSA countries. A substantial part of 
this variation could be explained by the differences in 
quality of healthcare governance, prevalence of HIV 
among the population of reproductive age and socio-
economic index across SSA countries. Even though we 
applied the appropriate statistical methods for analysis 
and the data used can be perceived as reliable data 
considering their sources, our findings could be threat-
ened by ecological fallacy; this seems, however, to be 
very unlikely for the observed relationship between the 
quality of healthcare governance and neonatal death. 
Residual confounding might have influenced the 
observed relationships as individual-level characteris-
tics could not be considered. In addition, the temporal 
relationship between neonatal mortality and country 
characteristics could not be established in this type of 
study. Thus, it is impossible to make a causal inference. 
Our study showed that in this region, more than half of 
the residents are living in poverty, 1 out of 20 people is 
HIV-infected and the scarcity of human and financial 
resources makes it difficult to provide adequate health 
services and other basic necessities of life such as safe 
water and education. Our analyses do not show spatial 
clustering in neonatal mortality among SSA countries. 
This spatial randomness might be due to the use of 
data at country-level rather than at province or district 
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level as employed in previous studies observing spatial 
clustering in childhood mortality and morbidity.7 8 The 
control chart analyses showed both common-cause and 
special-cause variation in neonatal mortality. Further 
examination of countries located below the control 
limits may identify factors that explain why these coun-
tries perform better than others. Similarly, countries 
above the control limits (>3 SD) should be thoroughly 
assessed to identify factors responsible for their excess 
incidence of neonatal mortality. While countries within 
the 99.8% control limits show no evidence of special-
cause variation, it remains to be explained why they 
have higher neonatal mortality rate than those below 
the control limits.
Globally, the leading direct causes of neonatal deaths 
are: prematurity/low birth weight, birth asphyxia, 
neonatal sepsis and birth trauma.1 Indirect factors also 
contribute to neonatal death by influencing neonatal 
survival at both individual level and population level.30 
The present study investigated the associations between 
neonatal mortality and indirect factors by identifying 
differences in country characteristics that might be 
responsible for the observed variations in neonatal 
mortality in SSA. Quality of healthcare governance 
was the strongest determinant of neonatal mortality 
in this study, although only 7 of the 49 SSA countries 
showed a positive rating in the quality of healthcare 
governance. To date, no previous studies in the litera-
ture have linked the quality of healthcare governance 
with neonatal mortality. Generally, emphasis has been 
placed on increasing health financing and health 
service coverage which is commendable, but only in the 
presence of good healthcare governance can this be 
fully effective. Without ensuring good quality in health-
care governance, scarce healthcare resources will not 
be used judiciously as shown by the results of a diag-
nostic public expenditure tracking survey conducted in 
Ghana, Uganda and Tanzania that demonstrated exten-
sive leakages of public funds in these three SSA coun-
tries.31 Thus, genuine commitment by governments is 
required to improve the quality of healthcare gover-
nance by ensuring transparency and accountability, 
government effectiveness, political stability, adherence 
to the rule of law, high regulatory quality and stiffer 
disciplinary action against corruption.
HIV prevalence among the population of reproduc-
tive age was positively associated with neonatal death, 
consistent with findings from a previous study that 
showed that neonates of HIV-positive mothers were 
more likely to die.32 This is yet another argument to 
promote prevention of mother-to-child transmission. 
Neonatal mortality declined as country’s socioeco-
nomic index improved, a result in line with previous 
studies observing that dwelling in a socioeconomically 
deprived population increases the risk of childhood 
morbidity and mortality.30 33–35 Similarly, a multicountry 
study that involved 13 SSA countries showed that 
the likelihood of dying at neonatal stage among the 
families in the poorest quintile was almost 70% higher 
than in the richest quintile.36 Implementing free 
basic education and poverty alleviation programme in 
conjunction with expansion of safe water supply and 
promotion of effective sanitation programme will help 
to improve neonatal survival. In conclusion, the results 
of this study based on data from 49 SSA countries show 
a marked variation in neonatal mortality. A substantial 
part of this variation can be explained by differences 
in health governance performance, prevalence of HIV 
and socioeconomic deprivation.
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